Chemical and Pharmaceutical Bulletin p. 1912 - 1916 (2000)
Update date:2022-08-29
Topics:
Wang, Feng-Peng
Yang, Jin-Song
Chen, Qiao-Hong
Yu, Lin
Li, Bo-Gang
New access to the 7, 17-seco norditerpenoid alkaloids 9 (60%) from yunnaconitine (5), as well as 14 (46%) and 15 (22%) from isotalatizidine (10), via selective hydrolysis, chlorination and reduction with NaBH4 is described.
View More
website:http://www.lidepharma.com
Contact:+86-25-58409506
Address:11F, Building A1, No.288 North Zhongshan Road, Gulou District, Nanjing,210003, P.R.China.
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Dongguan Albiya Energy Science and Technology Co.,Ltd
Contact:+86-769-22181286
Address:Huanan Industial Park, Dongguan,China
Contact:+86-21-38122007
Address:2, Lane 1123, Kangqiao Road, Pudong New Area, Shanghai
Doi:10.1016/j.bmcl.2016.02.031
(2016)Doi:10.1021/jacs.9b12940
(2020)Doi:10.1016/S0040-4020(01)97411-3
(1974)Doi:10.1016/j.jfluchem.2004.10.043
(2005)Doi:10.1080/10426507.2020.1756809
(2020)Doi:10.1021/cm903767n
(2010)
